DURHAM, N.C.--Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the German Institute for Medical Documentation and Information ...
Sirolimus analogues act through the same pathway as sirolimus. The restenosis casade that is initiated after stent implantation is shown in red. The mechanism of action of sirolimus (and analogues) is ...
Preliminary reports of studies involving simple coronary lesions indicate that a sirolimus-eluting stent significantly reduces the risk of restenosis after percutaneous coronary revascularization. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results